Proteins are nanomachines inside cells and perform the incredible array of tasks required for cells to function. They are composed of a chain of hundreds to thousands of amino acid “building blocks”. Peptides are similar to proteins, but have only about 3 to 30 amino acids. Their smaller size gives them distinct properties that are useful in therapeutic applications.
Menten AI is using cutting-edge generative methods to engineer new peptide therapeutics, and are backed by Y Combinator, Khosla Ventures, and others.
Patrick Finneran is the Associate Director of Biochemistry at Menten. He joins the show to tell us about the drug development process, handling noisy biological data, building a hybrid team of software engineers and biologists, and more.
Watch the video episode here:
The post Biotech Special: Computational Drug Discovery with Patrick Finneran appeared first on Software Engineering Daily.
